Institutional Ownership
Eupraxia Pharmaceuticals Inc
CUSIP 29842P105COMEPRXQ1 2026
Institutional Holders
54
13F filers
Shares Held
21.98M
Aggregate institutional
Institutional Value
$128.93M
Q1 2026
Net New Holders
+19
22 new · 3 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions22
Increased19
Decreased6
Sold out3
Institutional Holders
54 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Affinity Asset Advisors, LLC | 1.59M | $11.50M | +1.29M | Added |
| 2 | Balyasny Asset Management L.P. | 1.35M | $9.77M | 0 | Held |
| 3 | Vivo Capital, LLC | 1.35M | $9.77M | 0 | Held |
| 4 | Ikarian Capital, LLC | 1.21M | $8.79M | +604.7K | Added |
| 5 | Great Point Partners LLC | 1.20M | $8.69M | 0 | Held |
| 6 | Scotia Capital Inc. | 1.34M | $7.24M | +56.0K | Added |
| 7 | Point72 Asset Management, L.P. | 967.6K | $7.01M | +255.5K | Added |
| 8 | Ubs Group AG | 762.6K | $5.52M | +542.6K | Added |
| 9 | Redmile Group, LLC | 700.0K | $5.07M | +700.0K | New |
| 10 | Rubric Capital Management LP | 691.2K | $5.00M | +691.2K | New |
44 more institutional holders on Premium
See every fund holding Eupraxia Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders